唯赛勃(688718) - 2022 Q4 - 年度财报

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 31,378,366.40 for the year 2022[6]. - The company plans not to distribute profits for the 2022 fiscal year, with retained earnings carried forward to the next year[6]. - The company's operating revenue for 2022 was ¥308,048,369.97, a decrease of 18.76% compared to ¥379,186,008.35 in 2021[22]. - The net profit attributable to shareholders for 2022 was ¥31,378,366.40, down 37.84% from ¥50,479,049.29 in 2021[22]. - The net profit after deducting non-recurring gains and losses was ¥26,254,924.08, a decline of 45.41% from ¥48,097,549.31 in 2021[22]. - The company's total assets increased by 8.74% to ¥848,755,077.16 at the end of 2022, compared to ¥780,518,511.86 at the end of 2021[22]. - The net assets attributable to shareholders rose by 4.80% to ¥717,203,411.32 at the end of 2022, up from ¥684,326,314.04 at the end of 2021[22]. - Basic earnings per share for 2022 were ¥0.1806, a decrease of 46.90% from ¥0.3401 in 2021[23]. - The company's comprehensive gross profit margin was 31.02%, a decline of 3.82 percentage points from 34.84% in the previous year[34]. - The net cash flow from operating activities was ¥37,081,172.95, a decline of 9.00% year-on-year, primarily due to reduced cash inflow from declining product sales[24]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 6.91% in 2022, compared to 6.27% in 2021[23]. - The company invested ¥21,301,200 in R&D in 2022, maintaining the same level as in 2021, and obtained 32 new patents, particularly in seawater desalination and lithium extraction fields[38][39]. - The company is focused on optimizing talent acquisition across R&D, sales, quality control, production, and management to support sustainable development[39]. - The company has developed specialized membranes for lithium extraction, addressing specific downstream needs in the industry[56]. - The company is currently working on several key projects, including a PE substrate RO membrane with an expected total investment of ¥1,400,000, which has reached the pilot testing stage[76]. - The company has applied for 64 invention patents and 35 utility model patents during the reporting period, with a total of 220 applied and 167 authorized patents by the end of the period[71]. Market Environment and Challenges - The overall macroeconomic downturn and shrinking market demand posed significant challenges to the company's business development in 2022[33]. - The company achieved operating revenue of ¥308,048,369.97, a year-on-year decrease of 18.76%, and a net profit attributable to shareholders of ¥31,378,366.40, down 37.84% from the previous year[34]. - The company faces risks related to technological upgrades and the potential for new product development to fall short of expectations, which could negatively impact performance[94][95]. - The company is exposed to high overseas sales ratios, which may be affected by global economic challenges and trade protectionism[97]. - Raw material prices have increased significantly, impacting cost control and gross margin stability[99]. - The company is vulnerable to exchange rate fluctuations, particularly as a significant portion of revenue is generated from exports[103]. Governance and Compliance - The company has a standard unqualified audit report issued by the accounting firm[5]. - The company has established a governance structure that complies with legal regulations, ensuring effective decision-making and protection of shareholder rights[158]. - The company strictly adhered to information disclosure obligations, ensuring accuracy and timeliness throughout the reporting period[167]. - A total of 3 shareholder meetings were held during the reporting period, with all resolutions passed without any being rejected[171]. - The company has maintained independence in operations and governance, with no major discrepancies from regulatory requirements[167]. Production and Sales Strategy - The production plan is customer order-driven, with a focus on maintaining a safety stock of finished products to enhance delivery speed and service quality[51]. - The sales strategy combines direct sales and distribution through strong partnerships with distributors, expanding market reach beyond China to North America and Europe[54]. - The company is committed to R&D, continuously improving product formulations and production processes to meet high-performance targets such as high desalination rates and low energy consumption[56]. - The company has developed a comprehensive product system for reverse osmosis and nanofiltration membranes since 2011, continuously improving product performance and production efficiency[68]. Future Outlook - The company provided guidance for the next fiscal year, projecting revenue growth of A% and an expected EBITDA margin of B%[179]. - The company is focused on maintaining high-quality production standards and enhancing its manufacturing capabilities through automation and smart technology[154]. - The company plans to expand its production capacity by constructing a new facility capable of producing 300,000 composite material pressure tanks and 20,000 membrane element pressure vessels[147]. - The company aims to enhance its R&D capabilities by investing in advanced equipment and establishing a research center, focusing on customized membrane products for new application areas[152].